Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FSYG4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,768
Award facts
- Contract value 100% obligated
- $17,768.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 20, 2026, for Wegovy 1 mg/0.5 ml pens with a ceiling value of $17,768.45. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 21, 2026, and will be performed at the awardee's Conshohocken facility. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle valued through December 2031 that serves as the primary procurement mechanism for pharmaceutical and medical supplies supporting military healthcare programs globally.
This award demonstrates AmerisourceBergen's continued role as a critical pharmaceutical vendor for federal military medical procurement. The company's DLA IDC encompasses an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Wegovy delivery supports military and veteran healthcare systems' access to this diabetes and weight management medication, reflecting DLA's comprehensive approach to supplying diverse pharmaceutical products necessary for military treatment facilities and defense healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FSYG4?
SPE2DR26FSYG4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FSYG4 worth?
The government has obligated $17,768 on SPE2DR26FSYG4.
Is contract SPE2DR26FSYG4 an order under another contract?
Yes. SPE2DR26FSYG4 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSYG4 competed?
The extent of competition for SPE2DR26FSYG4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award